COMMD1, COMMD5, and COMMD10 are known to act as tumor suppressors, and their expression levels are reduced in several cancers including cancers, seminoma, melanoma, as well as kidney, pancreatic, colorectal, and ovarian cancers [25,27,72,73,74]. This evidence concerns the gene COMMD5 and neoplasm.